ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 239 filers reported holding ARRAY BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $605,000 | +260.1% | 13,080 | +10.8% | 0.00% | – |
| Q4 2018 | $168,000 | +3.1% | 11,808 | +9.7% | 0.00% | -100.0% |
| Q3 2018 | $163,000 | -74.5% | 10,763 | -71.7% | 0.00% | -66.7% |
| Q2 2018 | $639,000 | +2562.5% | 38,087 | +2400.8% | 0.00% | +200.0% |
| Q1 2018 | $24,000 | -93.1% | 1,523 | -96.3% | 0.00% | -93.3% |
| Q2 2017 | $348,000 | +3063.6% | 41,613 | +3269.5% | 0.02% | – |
| Q1 2017 | $11,000 | -92.4% | 1,235 | -96.4% | 0.00% | -100.0% |
| Q4 2015 | $145,000 | +30.6% | 34,411 | +126.6% | 0.01% | -15.4% |
| Q1 2015 | $111,000 | +26.1% | 15,186 | -17.9% | 0.01% | +18.2% |
| Q4 2014 | $88,000 | – | 18,508 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |